CAMBRIDGE, Mass. and VANCOUVER, British Columbia and BASEL, Switzerland, Oct. 21, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: EDIT), a ...

JonesTrading analyst Debanjana Chatterjee has assigned their bullish stance on NTLA stock, giving a Buy rating on October 16. Debanjana ...

Gene-editing therapies—techniques that modify DNA to treat or prevent disease—have the potential to transform the field of ...

As Shift Bioscience raises $16 million in seed funding, delve into the field of cellular reprogramming to tackle age-related ...

RIYADH, Saudi Arabia, Oct. 19, 2024 (GLOBE NEWSWIRE) -- (KFSHRC) is revolutionizing cancer treatment in the region with ...

The global market for Cell Therapy Biomanufacturing is valued at approximately USD 8.70 billion in 2023 and is expected to grow at a healthy compound annual growth rate (CAGR) of 11.5% during the ...

Chief, John Sterling, reviews Tim Harris's latest book, In Pursuit of Unicorns: A Journey through 50 Years of Biotechnology.

During October, Write On, Door County will present two programs that combine music with the written word. The first program ...

Intellia Therapeutics' innovative gene editing technology could revolutionize medicine, but investors need a strong stomach ...

CRISPR technology allows for precise DNA modifications, holding promise for treating genetic disorders and revolutionizing ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to ... system with RNA-sensing toehold switches, enabling precise gene modulation by activating CrRNA in response to specific trigger ...

A collaborative effort between investigators at the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) and Massachusetts General Hospital (MGH), a founding ...